Sally A. Prigent
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Melanoma and MAPK Pathways 3
- Glycosylation and Glycoproteins Research 3
- Fungal and yeast genetics research 2
- Oncology 7
- HER2/EGFR in Cancer Research 7
- Co-authors
- Nicholas R. Lemoine (2 shared papers)James R. Feramisco (4 shared papers)E A Hudson (2 shared papers)Matthew Squires (3 shared papers)Margaret M. Manson (3 shared papers)David R. Critchley (2 shared papers)Samrein B. M. Ahmed (4 shared papers)B.J. Smith (2 shared papers)
- Journals
- Biochemical Journal (5 papers)Journal of Biological Chemistry (3 papers)Biochemical Society Transactions (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)FEBS Letters (1 paper)
- Partner nations
- United KingdomUnited StatesUnited Arab Emirates
In The Last Decade
Sally A. Prigent
23 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 115
- Oncology 483
- Immunology and Allergy 106
- Cell Biology 188
- Molecular Biology 775
Countries citing papers authored by Sally A. Prigent
This map shows the geographic impact of Sally A. Prigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally A. Prigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally A. Prigent more than expected).
Fields of papers citing papers by Sally A. Prigent
This network shows the impact of papers produced by Sally A. Prigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally A. Prigent. The network helps show where Sally A. Prigent may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally A. Prigent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 315 | |
| 2 | 2003 | 166 | |
| 3 | 1996 | 138 | |
| 4 | 2000 | 78 | |
| 5 | 1992 | 72 | |
| 6 | 1997 | 68 | |
| 7 | 1999 | 67 | |
| 8 | 1994 | 62 | |
| 9 | 2000 | 53 | |
| 10 | 2017 | 41 | |
| 11 | 2000 | 41 | |
| 12 | 1999 | 39 | |
| 13 | 1995 | 30 | |
| 14 | 2010 | 24 | |
| 15 | 1997 | 18 | |
| 16 | 2000 | 18 | |
| 17 | 2013 | 10 | |
| 18 | 2012 | 4 | |
| 19 | 2019 | 3 | |
| 20 | 2018 | 3 |
About Sally A. Prigent
Sally A. Prigent is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (4 papers), Melanoma and MAPK Pathways (3 papers), Cell Adhesion Molecules Research (3 papers), Glycosylation and Glycoproteins Research (3 papers), Fungal and yeast genetics research (2 papers), Genetics, Aging, and Longevity in Model Organisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Molecular Medicine (115 citations), Oncology (483 citations), Immunology and Allergy (106 citations), Cell Biology (188 citations) and Molecular Biology (775 citations). Sally A. Prigent has collaborated with scholars based in United Kingdom, United States and United Arab Emirates. Frequent co-authors include Nicholas R. Lemoine, James R. Feramisco, E A Hudson, Matthew Squires, Margaret M. Manson, David R. Critchley, Samrein B. M. Ahmed, B.J. Smith, Mark D. Bass and Martin Dickens. Their work appears in journals such as Biochemical Journal, Journal of Biological Chemistry, Biochemical Society Transactions, The International Journal of Biochemistry & Cell Biology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.